A common skin bacterium can sneak into the bladder and physically "feed" a tumor to make it grow faster.
April 25, 2026
Original Paper
Pan-Cancer Circular Genomics Identifies Staphylococcus lugdunensis as a Metabolic Driver in Bladder Cancer
SSRN · 6642392
The Takeaway
Staphylococcus lugdunensis is typically found on the skin, but it can colonize the bladder and drive the progression of cancer. The bacterium secretes a specific lipid that plugs into the receptors of cancer cells and fuels their growth. This chemical signal essentially acts as a metabolic driver that accelerates the malignancy of the tumor. Patients with high levels of this specific microbe have much worse outcomes than those without it. Identifying and clearing this bacterium could become a standard part of treating bladder cancer to stop the tumor from receiving this external fuel. A common infection is acting as a secret collaborator for the cancer.
From the abstract
Intratumoral microbiota play key roles in cancer but are challenging to profile due to low biomass. We developed CIRCMIP, an enzymatic pipeline that eliminates linear DNA to enrich bacterial genomes, achieving 100-fold higher sensitivity than standard metagenomics. Applied to 312 pan-cancer specimens, CIRCMIP identified Staphylococcus lugdunensis as a signature bacterium enriched in early-stage bladder cancer (BLCA), where its presence predicts poor survival. Integrated modeling and lipidomics r